WMSA
NVAX icon

Weiss Multi-Strategy Advisers’s Novavax NVAX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-500
Closed -$51K – 1074
2013
Q4 		$51K Buy
+500
New +$35.3K ﹤0.01% 957

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Weiss Multi-Strategy Advisers's NVAX Position: Q1 2015 in Review

Weiss Multi-Strategy Advisers sold out of Novavax (NVAX) in Q1 2015, closing a stake of 1,000 shares — an estimated $119K sold.

Weiss Multi-Strategy Advisers first reported a position in NVAX in Q3 2013 and held it in 6 quarters. The position peaked at $295K in Q1 2014. 167 funds tracked by Wall St. Rank hold NVAX as of Q1 2015.

  • Weiss Multi-Strategy Advisers reported no remaining Novavax position as of Q1 2015 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 1,000 Novavax shares in Q1 2015, an estimated $119K.
  • Weiss Multi-Strategy Advisers first reported a position in Novavax in Q3 2013 and held it in 6 quarters.
  • Weiss Multi-Strategy Advisers's Novavax position peaked at $295K in Q1 2014.
  • 167 funds tracked by Wall St. Rank held Novavax as of Q1 2015.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2015, filed 15 May 2015.